Around Fox Chase

A pioneering leader in cancer immunotherapy, Louis M. Weiner, MD, Director of Georgetown University’s Lombardi Comprehensive Cancer Center, delivered the 2025 Robert L. Krigel Endowed Memorial Lecture at Fox Chase Cancer Center.

A career defined by scientific curiosity, family collaboration, and global perspective has led Edna “Eti” Cukierman, PhD, to a national stage, where her expertise in the tumor microenvironment, the ecosystem around tumors, will help shape the future of cancer research.

Michael J. Hall, MD, MS, FASCO, Chair of the Department of Clinical Genetics at Fox Chase Cancer Center, joined national experts to show how genetics and social factors collide in survivorship — and how smarter policies can bridge the gap.

Fox Chase Cancer Center earned its sixth AAHRPP reaccreditation, highlighting its commitment to ethical, patient-focused research.

The Winn Award will support Cann in his work to close longstanding care gaps for young adult cancer patients and build a national model that strengthens trial access, fertility preservation, and supportive services.

Fox Chase Cancer Center recently hosted its annual End-of-Life Care Symposium, a full-day academic program designed to advance team-based approaches to caring for patients at the end of life. What began as a focused educational offering for nurse residents has grown into a system-wide and increasingly region-wide event, drawing participants not only from across Temple Health but also from external institutions.

This employee recognition event highlights excellence in achieving the organizational goals, leadership competencies, and core values of Fox Chase.

Fox Chase Cancer Center is pleased to announce the hiring of Samuel J. Ivan, MD, as an Assistant Professor in the Department of Urology and the Fox Chase – Temple Urologic Institute. In addition to seeing patients at the main campus and Fox Chase – Voorhees, Ivan will also provide services at Temple Health – Jeanes Campus and Temple Health – Main Campus.